The effectiveness of combining surgery with chemo- and radiation thera
py in treatment of human cancer provides a useful model for further de
velopment of new multimodality approaches including laser photochemoth
erapy. Laser endoscopy often is a useful treatment for obstructive tum
ors in airways, but interstitial laser fiberoptics is becoming a more
precise, minimally invasive alternative for ablation of unresectable o
r recurrent neoplasms. Combining intratumor chemotherapy with laser en
ergy delivery via interstitial fiberoptics should be most effective us
ing drugs activated by photothermal energy. A number of investigators
have shown that anthracyclines and cis-platinum are likely candidates
for light or heat activation in cancer cells. An advantage of anthracy
clines is their dual role as antitumor drugs and as photosensitizers.
Because they are effective chemotherapy agents without photoactivation
, two approaches are possible to increase tumor responses. Maximum tol
erated dose followed by photoillumination via laser fiberoptics can be
used to obtain better tumor palliation. Improved treatment response t
o lower intratumor drug levels after laser activation also should redu
ce systemic toxicity. Preclinical studies and recent case reports from
several groups suggest photochemotherapy with currently approved drug
s and lasers may soon become an attractive alternative for treatment o
f recurrent tumors in cancer patients. (C) 1995 Wiley-Liss, Inc.